Investigating immune system issues in rosacea
Official title: Multi-omic Studies of Local and Systemic Immune Dysregulation in Rosacea
Funded at Brigham and Women's Hospital · NIH-11017775 · Data updated 2026-11-12
This study is looking at how the immune system works differently in people with rosacea, a skin condition, to find new ways to prevent and treat it, so that those affected can feel better and improve their skin health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brigham and Women's Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | February 6, 2023 |
| Project end | January 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $169,884 |
| NIH project number | 5K23AR080203-04 |
| Project ID | NIH-11017775 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with rosacea, particularly those experiencing significant symptoms.
✕Less likely to help
Patients with other skin conditions unrelated to rosacea may not benefit from this research.
What this research studies
This research focuses on understanding how the immune system is dysregulated in patients with rosacea, a common inflammatory skin condition. By examining the interactions between skin microbiota and the immune response, the study aims to identify new preventative and therapeutic strategies for rosacea. The researchers will utilize advanced techniques to analyze various biological data from the skin of rosacea patients, which may reveal important insights into the disease's underlying mechanisms. Ultimately, the goal is to improve health outcomes for individuals affected by rosacea.
Why it matters
Potential benefit: If successful, this research could lead to new treatments and preventive measures for rosacea, enhancing the quality of life for patients.
How similar studies have gone: Previous research has shown promise in understanding immune dysregulation in skin diseases, suggesting that this approach may yield valuable insights.
Where this research is happening
-
Brigham and Women's Hospital
Boston, United States Active
Researchers
- Principal investigator: Mcgee, Jean Suh — Brigham and Women's Hospital
- Study coordinator: Mcgee, Jean Suh
Related research
Other NIH-funded projects on the same topics.
-
Targeted therapies for glioblastoma in adults and kids
A large NIH program is exploring new brain cancer therapies, including drugs that reach the brain and work against glioblastoma in both children and adults.
-
Statins to Prevent Cancer-Associated Blood Clots in Cancer Patients
A large study will test whether taking rosuvastatin every day for a year can lower the chance of dangerous blood clots in people with cancer, without raising the risk of bleeding.
-
Preterm infant body composition and early-life health after NICU stay
This grant studies how body composition in very preterm babies relates to later brain development and risk of obesity or diabetes, with findings meant to improve care from NICU through early childhood.
-
Rapid Emergency Skills for Prehospital Optimization and Delivery (RESPOND) for Guatemala
A lightweight, AI-enabled prehospital training and triage program helps volunteer firefighters in Guatemala deliver faster, better care to trauma patients.
-
Rapid Emergency Skills for Prehospital Optimization and Notification in Guatemala
A mobile, AI-powered training and triage program helps volunteer emergency responders in Guatemala provide faster, safer trauma care and notify hospitals more quickly.
-
Understanding antibiotic allergy to improve care for patients
Scientists are testing new ideas to understand why some people develop severe allergic reactions to antibiotics and how to prevent or treat them.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.